Regulators Encourage Transition from Batch to Continuous Processing
This article was originally published in The Gold Sheet
Executive Summary
As pharmaceutical manufacturers increasingly look to continuous processing technologies as a way of controlling costs and potentially increasing drug quality, regulators in the U.S. and the European Union are beginning to use more flexible, quality-by-design-like approaches in evaluating these systems.